Greenberg Traurig is proud to sponsor the 8th Annual Emerging Frontiers in Oncology summit on June 4 at the MassBio Hub. This off-the-record event will bring together leaders across the oncology ecosystem — including investors, biopharma executives, entrepreneurs, researchers, and foundations — to explore the evolving landscape of complex biologics and the emerging opportunities shaping the future of cancer innovation.
As part of the program, Greenberg Traurig Shareholder Prashant Girinath will moderate the Innovation Panel, “In the Recovery Market, Where Should Capital Be Deployed?” at 2:50 p.m. This debate-style session will explore evolving investment strategies across oncology and life sciences, focusing on where capital is being directed, emerging areas of opportunity, and the market dynamics shaping innovation in a rapidly changing landscape.